Theo van Os

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

Elizabeth Bancroft, Elizabeth Page, Elena Castro et al. · European Urology · 2014 · 251 citations · Full text

Medicine, Genetics, Oncology +17

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Elizabeth Page, Elizabeth Bancroft, Mark N. Brook et al. · European Urology · 2019 · 240 citations · Full text

Medicine, Oncology, Urology +17

Heterozygous Mutations in PMS2 Cause Hereditary Nonpolyposis Colorectal Carcinoma (Lynch Syndrome)

Yvonne Hendriks, Shantie Jagmohan–Changur, Heleen M. van der Klift et al. · Gastroenterology · 2006 · 154 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Anna Marie Mulligan, Fergus J. Couch, Daniel Barrowdale et al. · Breast Cancer Research · 2011 · 118 citations · Full text

Medicine, Genetics, Oncology +17

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Christos Mikropoulos, Christina G. Selkirk, Sibel Saya et al. · British Journal of Cancer · 2018 · 20 citations · Full text

Medicine, Oncology, Urology +17